Renata PLC announcements
340 Dhaka Stock Exchange announcements for Renata PLC (RENATA) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2022 (27).
- Dividend Disbursement
The Company has informed that it has credited the Bonus shares for the year ended June 30, 2022 to the respective shareholders' BO Accounts.
- WHO (Geneva) Approval for Rajendrapur Potent Product Facility (RPPF)
The Company has informed that WHO (Geneva) has approved Rajendrapur Potent Product Facility (RPPF) of the Company and this approval shall permit them to bid in tenders for birth control pills in most countries. The Company has also informed that RPPF is the only factory in Bangladesh that has received WHO prequalification for birth control pills.
- Q1 Financials
(Continuation news of RENATA): Reasons for significant deviation: NOCFPS has decreased due to increase in payment for cost and expenses. (end)
The first part of this announcement is missing from the archive. - Resumption after record date
Trading of the shares of the Company will resume on 13.11.2022 after record date
- Suspension for Record date
Trading of the shares of the company will remain suspended on record date i.e., 10.11.2022
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 12, 2022 at 2:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2022.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 08.11.2022 to 09.11.2022 and trading of the shares will remain suspended on record date i.e., 10.11.2022.
- USFDA Approval for General Plant-2
The Company has informed that Renata Limited General Plant-2 (Rajendrapur General Facility) has been approved by USFDA. The inspection was triggered with Metoprolol Tartrate tablets. Renata has seven products (ANDAs) registered in the US. Of these products, Rolip (Rosuvastatin) is also sold in Bangladesh. Presently, the UK and EU are major export market for Renata. However, with this approval, the Company expects to make inroads into the US market with plain generics, Para IV and NCE-1 filings
- Emphasis of Matter
(Continuation news of RENATA): on 01 March 2022 approved the amalgamation of Renata Agro Industries Limited and Purnava Limited with the company, whereby the Subsidiaries will merge with the company and the company shall be the surviving entity. Our opinion is not modified in respect of this matter. The financial statements reflect financial result of the amalgamated entity. (end)
The first part of this announcement is missing from the archive. - Dividend Declaration
(Continuation news of RENATA): iii) Bonus shares are not declared from capital reserve or revaluation reserve or any unrealized gain or out of profit the earned prior to incorporation of the Company or through reducing paid up capital or through doing anything so that the post-dividend retained earnings become negative or a debit balance. (end)
The first part of this announcement is missing from the archive. - Price Limit Open
There will be no price limit on the trading of the shares of the Company today (23.10.2022) following its corporate declaration.
- Update of Information
(Continuation news of RENATA): If anyone fails to provide his/her e-TIN, Tax to be deducted @15% instead of 10% (individual) as per amended Income Tax Ordinance No. XXXVI of 1984 under Section 54. The Company has also requested the shareholders to check and update their BOID's e-mail address, mobile number and Bank Account details alone with Routing Number to get Dividend online through BEFTN system. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 22, 2022 at 12:30 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2022.
- Q3 Financials
(Q3 Un-audited): Consolidated EPS was Tk. 12.76 for January-March 2022 as against Tk. 11.55 for January-March 2021; Consolidated EPS was Tk. 38.38 for July 2021-March 2022 as against Tk. 33.94 for July 2020-March 2021. Consolidated NOCFPS was Tk. 18.54 for July 2021-March 2022 as against Tk. 30.00 for July 2020-March 2021. Consolidated NAV per share was Tk. 265.10 as on March 31, 2022 and Tk. 239.86 as on June 30, 2021.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 27, 2022 at 2:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2022.
- Buy confirmation of a Corporate Director
Sajida Foundation, one of the Corporate Directors of the company, has further reported that it has completed its buying of 22,000 shares of the company at prevailing market price through Dhaka Stock Exchange as per declaration disseminated on 16.03.2022.
- Resumption after record date
Trading of the shares of the Company will resume on 24.03.2022 after record date.
- Suspension for Record date
Trading of the shares of the Company will remain suspended on record date i.e., 23.03.2022 for EGM.
- Spot for EGM
Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle from 21.03.2022 to 22.03.2022. Trading of the shares of the Company will remain suspended on record date i.e., 23.03.2022 for EGM.
- Buy declaration of a Corporate Director
Sajida Foundation, one of the Corporate Directors of the company, has expressed its intention to buy 22,000 shares of the Company at prevailing market price (in the Public Market) through Dhaka Stock Exchange Limited within next 30 working days, as per Rule-4 of the BSEC (Substantial Acquisition of shares and Takeovers), Rules, 2018.
- Decision to purchase land
The Company has informed that the Board of Directors has decided to purchase of 560 decimals land along with a carton factory at Mouza-Dogri, Rajendrapur, Gazipur at a cost of BDT 51.00 crore excluding registration and incidental cost. The land will be used for expansion of Ranjendrapur factory, Gazipur.
- Permission to remit USD as paid up capital
The Company has informed that it has got permission from Bangladesh Bank to remit USD 2,000,000.00 from its Exporters' Retention Quota (ERQ) account to Renata Pharmaceuticals (Ireland) Limited and USD 5,000,000.00 from its ERQ account to Renata (UK) Limited as paid up capital.
- Amalgamation with two subsidiary Companies
(Continuation news of RENATA): with their all assets and liabilities as per provisions of Section 228 and 229 of the Companies Act, 1994. In this respect, the Draft Scheme of Amalgamation was unanimously approved by the Board of Directors of the Company. (end)
The first part of this announcement is missing from the archive. - Q2 Financials
(Continuation news of RENATA): The Company has also informed that increase in payment for cost and expenses during July to December 2021 in the normal course of business resulted in increased cash outflow and reduction in net operating cash flow compared to July to December 2020. (end)
The first part of this announcement is missing from the archive. - Dividend Disbursement
The Company has informed that it has disbursed the cash dividend for the year ended June 30, 2021 to the respective shareholders.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 29, 2022 at 12:00 Noon to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2021.
- Dividend Disbursement
The Company has informed that it has credited the Bonus shares for the year ended on June 30, 2021 to the respective shareholders' BO Accounts on January 04, 2022.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.